PT - JOURNAL ARTICLE AU - McErlane, Flora AU - Davies, Elin Haf AU - Ollivier, Cecile AU - Mayhew, Anna AU - Anyanwu, Obuchinezia AU - Harbottle, Victoria AU - Donald, Aimee TI - Wearable technologies for children with chronic illness: A Proof-of-Concept Study AID - 10.1101/2020.10.25.20219139 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.25.20219139 4099 - http://medrxiv.org/content/early/2020/10/27/2020.10.25.20219139.short 4100 - http://medrxiv.org/content/early/2020/10/27/2020.10.25.20219139.full AB - Objective To determine the feasibility of wearable technologies in physical activity assessment in three paediatric diseases, namely Niemann-Pick C (NP-C), Juvenile Idiopathic Arthritis (JIA) and Duchenne Muscular Dystrophy (DMD).Design Proof of concept feasibility studySetting and patients Thirty children were recruited across three UK hospitals (Royal Manchester’s Children Hospital, Great Ormond Street Children’s Hospital and the Great North Children’s Hospital). Ten were diagnosed with NP-C, eight with DMD and twelve with JIA.Intervention All participants completed the 6-minute walk test (6MWT) at enrolment. Patients were provided with disease specific smartphone apps paired with a wearable device via Bluetooth. Ambulation was recorded in 30-minute epochs measuring average daily maximum (ADM), average daily steps (ADS), and average daily steps per 30-minute epoch (ASE).Results Median 6MWT results were 450m, 325m and 434.5m for the NP-C, DMD and JIA cohorts respectively. Wearable data capture was feasible in all three disease groups, although complete data capture was not sustained. A statistically significant between-cohort difference was identified for ADM, ADS and ASE. Statistically significant differences were found between DMD/JIA for ADM; NP-C/DMD for ADS and DMD/JIA for ASE.Discussion Wearable sensor technologies have the potential to add important information to our understanding of ambulation in chronic paediatric disease. The wearable devices were easy to use and popular with patients although key features need to be addressed to ensure higher engagement in future deployments. As the technology continues to evolve at a rapid pace, opportunities to implement child friendly solutions are already available.Competing Interest StatementElin Haf Davies and Cecile Ollivier are employees of Aparito and holds shares. The authors received no funding for the writing of this manuscript. Funding StatementPart of this work was supported by Actelion Pharmaceuticals.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the NRES Committee London - City & East and Bristol Research Ethics Committee Centre (REC reference: 15/LO/0528; IRAS project ID: 174833). Patients were recruited from Royal Manchester Children Hospital, Great Ormond Street Children Hospital and the Great North Children Hospital in the UK. Parental consent was obtained, and child assent where relevant.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available upon reasonable request